Parameswaran Hari
Chief Medical OfficerDr. Parameswaran Hari, M.D., M.S., is Chief Medical Officer of Obsidian Therapeutics, Inc. from January 2023. Dr. Hari is the Professor of Hematology at Medical College of Wisconsin. Dr. Hari serves as Chief Development Officer at Obsidian Therapeutics, Inc. since March 2023. Dr. Hari serves as Chief of the Division of Hematology and Oncology in the Department of Medicine at the Medical College of Wisconsin. After medical school in India, he completed training in Internal Medicine and Hematology at premier institutions in United Kingdom and then in Medical Oncology and Transplantation at the Medical College of Wisconsin. His primary clinical interests are in hematopoietic stem cell transplantation and cell therapies, plasma cell disorders and other blood cancers. Dr. Hari is also Scientific Director of the plasma cell disorders working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Dr. Hari received his M.B.B.S at Kerala University, M.D. at Central University of Pondicherry and his M.S. at the Medical College of Wisconsin.
Positions
- Company NameObsidian Therapeutics, Inc.Stock CodeOBXPositionChief Medical OfficerColleagues
